What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
How do you use 105%, 107% and max dose metrics differently compared with non-reconstructed cases?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
I try to follow the same as intact breast.
Limiting hot spot < 110 and V 105 < 5-10% and not hot spot in IM fold.
Join for free or sign in to see the full answer